Literature DB >> 70168

Cytochemical "normal" and "abnormal" eosinophils in acute leukemias.

V Liso, G Troccoli, G Specchia, M Magno.   

Abstract

Eosinophilic leukocytes may accompany a great variety of disorders and different types of acute leukemias. The most striking morphologic feature of eosinophils is their specific granules, but morphology alone often is insufficient to differentiate normal from abnormal eosinophils. Cytochemically, the eosinophils were considered "normal" when they did not contain alkaline phosphatase, chloroacetate esterase, toluidine blue metachromasia, Astra blue positivity, and specific PAS-positive granules, but did have peroxidase and cyanide-resistant peroxidase activities, Sudan black positivity and moderate naphthol-AS esterase or alpha-naphthyl esterase and acid phosphatase positivities. In seven cases of acute leukemias (two acute myeloblastic and five myelomonocytic), in contrast with their normal behaviour, the eosinophils show "abnormal" cytochemical positivities consisting of chloroesterase activity, PAS and Astra blue positivities of the specific granules, toluidine blue metachromasia, and cyanide-resistant peroxidase of a few specific granules. Cytochemical investigations may provide additional criteria for evaluating the abnormality of the eosinophilic cell in leukemias.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70168     DOI: 10.1002/ajh.2830020204

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Platelet satellitism to basophils in a patient with chronic myelocytic leukaemia.

Authors:  V Liso; L Bonomo
Journal:  Blut       Date:  1982-11

2.  Cocktail of Periodic Acid-Schiff and Papanicolaou: Novel staining technique for the identification of leukemic eosinophils - A pilot study.

Authors:  Lavanya Mallika; S V Sowmya; Roopa S Rao; Dominic Augustine; Vanishri C Haragannavar; K Shwetha Nambiar
Journal:  J Oral Maxillofac Pathol       Date:  2019 Sep-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.